JP Morgan analysts reiterated a Neutral rating on HCA Healthcare, Inc. (NYSE:HCA) on February 20, 2026.
HCA Healthcare, Inc. operates in the Healthcare sector. The stock currently trades at $532.30 with a market capitalization of $117.1B.
JP Morgan analysts reiterated a Neutral rating on HCA Healthcare, Inc. (NYSE:HCA) on February 20, 2026. HCA Healthcare, Inc.

JP Morgan analysts reiterated a Neutral rating on HCA Healthcare, Inc. (NYSE:HCA) on February 20, 2026.
HCA Healthcare, Inc. operates in the Healthcare sector. The stock currently trades at $532.30 with a market capitalization of $117.1B.
Current market data
NYSE · HCA
$494.99
Down: -$12.49 · -2.46%
Live quote updated
Keep reading
analyst ·
analyst ·
analyst ·
analyst ·